Memory and cognitive disorders are mental health disorders that primarily affect learning, memory, perception and problem solving ability. The global Therapeutics for Memory and Cognition Disorders Market is witnessing a significant growth over recent years due to aging population in different parts of the world, new drugs development and better understanding of drugs mechanism. However, less number of approved drugs is a major restraint for the market growth. Also, ethical implication has become a major challenge for the market.
Global market of therapeutics for memory and cognition disorders is primarily divided into two segments: based on application and based on mechanisms of action for the treatment. On the basis of applications, memory and cognition disorders treatment market is primarily subdivided into primary and secondary disorders which mainly include Alzheimer’s disease, vascular dementia, Lewy body dementia, Parkinson’s disease and Schizophrenia.
Request to View Brochure of Report –
Further, the area of mechanism of action for the treatment is also sub-divided into two segments: common mechanisms and development in cognition enhancer. Some of the major players operating in the market are Merck, Roche, Pfizer, Shire and Cephalon.